TrialNature medicine2026

15-strain live biotherapeutic product or same donor fecal microbiota transplant for recurrent Clostridioides difficile infection: a randomized phase 1b trial.

Lukas Bethlehem et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.